1-10 of 10
Ephraim J. Fuchs, MD MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Assessing the Importance of Conditioning Regimen, Donor Choice, and Tyrosine Kinase Inhibitor Use

Jonathan Webster, MD, Leo Luznik, MD, Hua-Ling Tsai, ScM, Philip H. Imus, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, Mark Levis, MD PhD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T. Prince, MD, Javier Bolanos-Meade, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, William Brian Dalton, MD PhD, Tania Jain, MD, Ephraim J. Fuchs, MD MBA, Douglas E Gladstone, MD, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-141294
Published: 2020
Journal Articles

Reduced-Intensity Induction with Dasatinib Vs. Hypercvad + 2 nd Generation TKIs with MRD-Guided Follow-up Therapy Leads to Comparable Rates of MRD-Negative Remission While Reducing Transfusions and Neutropenia in Ph+ ALL

Jonathan Webster, MD, Hua-Ling Tsai, ScM, Eric Gehrie, Tania Jain, MD, Christopher S. Hourigan, MDDPhil, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, Amy E. DeZern, MD, Margaret M. Showel, MD, Ivana Gojo, MD, Douglas E Gladstone, MD, Philip H. Imus, MD, Javier Bolanos-Meade, MD, Leo Luznik, MD, Ephraim J. Fuchs, MD MBA, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD, Mark Levis, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-141264
Published: 2020
Journal Articles

Improving Donor Selection for Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide through Selective HLA-Mis/Matching

Ephraim J. Fuchs, MD MBA, Shannon R McCurdy, MD, Scott R. Solomon, MD, Tao Wang, PhD, Michelle Kuxhausen, MS, Yvette L Kasamon, MD, MHD Monzr Al Malki, MD, Shahinaz Gadalla, MD PhD, Sophie Paczesny, MDPhD, Steven GE Marsh, BSc, PhD ARCS, Bronwen E. Shaw, PhD MRCP, FRCPath, Stephen R. Spellman, MS, Stephanie J. Lee, MDMPH, Effie Petersdorf, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–26.
https://doi.org/10.1182/blood-2020-140433
Published: 2020
Journal Articles

Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens

Mahasweta Gooptu, MD, Andrew St. Martin, MS, Rizwan Romee, MD, Mukta Arora, MD, Monzr M. Al Malki, MD, Joseph H. Antin, MD, Christopher Bredeson, MDFRCPC,MSc, Claudio G. Brunstein, MD PhD, Saurabh Chhabra, MD, Ephraim J. Fuchs, MD MBA, Nilanjan Ghosh, MD PhD, Michael R. Grunwald, MD, Yoshihiro Inamoto, MD, Christopher G. Kanakry, MD, Natasha Kekre, MD MPH, FRCPC, Joseph P. McGuirk, DO, Ian K. McNiece, PhD, Rohtesh S. Mehta, MDMPH,MS, Marco Last Mielcarek, MD, Filipo Milano, MD PhD, Dipenkumar Modi, MD, Ran Reshef, MD, Mark A. Schroeder, MD, Robert J. Soiffer, MD, Scott R. Solomon, MD, Edmund K. Waller, PhDMD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-137221
Published: 2020
Journal Articles

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Scott R Solomon, MD, Andrew St. Martin, MS, Nirav N Shah, MD, Giancarlo Fatobene, MD, Monzr Al Malki, MD, Karen K. Ballen, MD, Asad Bashey, MD PhD, Nelli Bejanyan, MD, Javier Bolaños-Meade, MD, Claudio G Brunstein, MD PhD, Zachariah Defilipp, MD, Richard E Champlin, MD, Ephraim J. Fuchs, MD MBA, Mehdi Hamadani, MD, Peiman Hematti, MD, Christopher G. Kanakry, MD, Joseph P. McGuirk, DO, Ian K. McNiece, PhD, Stefan O. Ciurea, Marcelo C. Pasquini, MD, Vanderson Rocha, MD PhD, Rizwan Romee, MD, Sagar S. Patel, MD, Sumithira Vasu, MDMBBS, Edmund K. Waller, MD, John R. Wingard, MD, Mei-Jie Zhang, PhD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1015.
https://doi.org/10.1182/blood-2018-99-110814
Published: 2018
Journal Articles

Nonmyeloablative (NMA), HLA-Haploidentical (Haplo) Blood or Marrow Transplantation (BMT) from Non-First-Degree Related Donors Has Similar Outcomes to First-Degree Related BMT

Hany Elmariah, MDMS, Yvette L Kasamon, MD, Marianna Zahurak, MS, Noah Tucker, CCRC, Gary Rosner, ScD, F Javier Bolanos-Meade, MD, Ravi Varadhan, PhD, Ephraim J. Fuchs, MD MBA, Amy E. DeZern, MD, Leo Luznik, MD, Richard J. Jones, PhD, Richard F Ambinder, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3304.
https://doi.org/10.1182/blood.V130.Suppl_1.3304.3304
Published: 2017
Journal Articles

FLT3 ITD AML Outcomes Are Impacted By Exposure to One Cycle of Cytarabine Based Consolidation, Pre- and Post-Transplant TKI Therapy, and Presence of Minimal Residual Disease (MRD) Prior to Allogeneic Blood or Marrow Transplant

Melanie Rebechi, Amy E. DeZern, MD, Amanda Kagan, MD, B. Douglas Smith, MD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T. Prince, MD, Gabriel Ghiaur, MD PhD, Lukasz P. Gondek, MD PhD, William Matsui, MD, Ephraim J. Fuchs, MD MBA, Leo Luznik, MD, Shannon R. McCurdy, MD, Carol Ann Huff, MD, Lode J. Swinnen, Ivan M. Borrello, MD, Douglas E. Gladstone, MD, Javier Bolanos-Meade, MD, Richard F Ambinder, MD, Richard J. Jones, MD, Mark J. Levis, MD, Keith Pratz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2593.
https://doi.org/10.1182/blood.V130.Suppl_1.2593.2593
Published: 2017
Journal Articles

Grade II Acute Gvhd Improves Progression-Free Survival after Myeloablative HLA-Matched Bone Marrow Transplant with Posttransplantation Cyclophosphamide

Shannon R. McCurdy, MD, Christopher G. Kanakry, MD, Hua-Ling Tsai, ScM, Javier Bolaños-Meade, MD, Ephraim J. Fuchs, MD MBA, Gary Rosner, ScD, Richard J. Jones, MD, Leo Luznik, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 216.
https://doi.org/10.1182/blood.V130.Suppl_1.216.216
Published: 2017
Journal Articles

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Conrad Russell Young Cruz, MD PhD, Sarah McCormack, BA, Kaylor Elizabeth Wright, BS, Allison B Powell, BS, Haili Lang, MS, Cecilia Barese, MDPhD, Connie Trimble, MD, Michael Keller, MD, Ephraim J. Fuchs, MD MBA, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1923.
https://doi.org/10.1182/blood.V130.Suppl_1.1923.1923
Published: 2017
Journal Articles

Selecting between HLA-Matched Siblings and HLA- Haploidentical Related Donors for Acute Leukemia in the Era of Post-Transplant Cyclophosphamide: The Center for International Blood and Marrow Transplant Registry and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant

Tara M. Robinson, MD PhD, Ephraim J. Fuchs, MD MBA, Mei-Jie Zhang, PhD, Myriam Labopin, MD PhD, Andrew St. Martin, MS, Daniel A Keesler, BS, Didier Blaise, Asad Bashey, MD PhD, Jean-Henri Bourhis, Fabio Ciceri, MD, Stefan O. Ciurea, Steven M. Devine, MD, Mohamad Mohty, MD PhD, Shannon R. McCurdy, MD, Noel Milpied, Ian K. McNiece, PhD, Vanderson Rocha, MD PhD, Rizwan Romee, MD, Gerard Socie, MD PhD, Ibrahim Yakoub-Agha, Robert J. Soiffer, MD, Mary Eapen, MBBS, MS, Arnon Nagler, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 851.
https://doi.org/10.1182/blood.V130.Suppl_1.851.851
Published: 2017